Cynosure, Inc. Earnings Conference Call (Q2 2009)  Today's Calls

Visit the TF Network Sites· Corporate IR Center · Institutional Investor Center · Individual Investor Center Download Plug-In Real Player 8 Basic Windows Media Player Other Conference Calls Other Jul 28 Calls Today's Calls

Call Details Cynosure, Inc. Earnings Conference Call (Q2 2009) Tue, Jul 28, 2009, 9:00 am Eastern Listen to the archived event audio About Cynosure, Inc. (NasdaqGM:CYNO) Other Calls  Cynosure, Inc. develops and markets aesthetic treatment systems to the dermatology, plastic surgery, and general medical markets. Its systems incorporate a range of laser and other light-based energy sources, including Alexandrite, pulse dye, Nd:Yag, and diode lasers, as well as intense pulsed light. The company offers 18 different aesthetic treatment systems, including the Apogee Elite system for hair removal; the Cynergy system for the treatment of vascular lesions; the TriActive LaserDermology system for the temporary reduction of the appearance of cellulite; the Affirm and Affirm CO2 systems for anti-aging, including treatments for wrinkles, skin texture, skin discoloration and skin tightening; the Smartlipo and Smartlipo MPX systems for LaserBodySculpting for the removal of unwanted fat; and Accolade system for the removal of benign pigmented lesions, including pigmented lesions known as Nevus of Ota and Nevus of Ito, as well as multi-colored tattoos. Cynosure sells its products through a direct sales force in North America, 4 European countries, Japan, and China, as well as through international distributors in 55 other countries. The company was founded in 1991 and is based in Westford, Massachusetts. More Info: Quote | Profile | Reports | Research | Msgs | Insider | Financials | Analyst Ratings